Earnings Call · Q2 FY2023·2023-08-08

Q2 23EPS +7.20%·Rev n/aQ1 23EPS -3.97%·Rev n/aQ4 22EPS +16.90%·Rev n/aQ3 22EPS -8.00%·Rev n/a⚠ consensus missing

Arcutis Biotherapeutics, Inc. ARQT

−4.5%1d on move date−3.8% vs SPY3d−8.9%5d−13.8%

Research tier

Behavioral profile computed for this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ARQT calls or request research access.

More ARQT calls Browse calls Request research access